{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T20:34:21Z","timestamp":1760646861291,"version":"build-2065373602"},"reference-count":71,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"name":"Regional Offender Health Unit"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofsubstanceabusetreatment.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Substance Abuse Treatment"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1016\/j.jsat.2018.07.002","type":"journal-article","created":{"date-parts":[[2018,7,4]],"date-time":"2018-07-04T07:23:03Z","timestamp":1530688983000},"page":"91-98","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["High drug related mortality rates following prison release: Assessing the acceptance likelihood of a naltrexone injection and related concerns"],"prefix":"10.1016","volume":"92","author":[{"given":"Philip N.","family":"Murphy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Faizal","family":"Mohammed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michelle","family":"Wareing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angela","family":"Cotton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"McNeill","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paula","family":"Irving","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steve","family":"Jones","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7256-8717","authenticated-orcid":false,"given":"Louisa","family":"Sharples","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rebecca","family":"Monk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Elton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"author":"Accord Healthcare","key":"10.1016\/j.jsat.2018.07.002_bb0005"},{"key":"10.1016\/j.jsat.2018.07.002_bb0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta11060","article-title":"Oral naltrexone as a treatment for relapse prevention in formerly opioid-dependent drug users: A systematic review and economic evaluation","volume":"11","author":"Adi","year":"2007","journal-title":"Health Technology Assessment"},{"key":"10.1016\/j.jsat.2018.07.002_bb0015","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1093\/bjc\/azi001","article-title":"The links between heroin, crack cocaine and crime","volume":"45","author":"Allen","year":"2005","journal-title":"British Journal of Criminology"},{"key":"10.1016\/j.jsat.2018.07.002_bb0020","doi-asserted-by":"crossref","first-page":"1,080","DOI":"10.1136\/bmj.332.7549.1080","article-title":"The cost of dichotomising continuous variables","volume":"332","author":"Altman","year":"2006","journal-title":"British Medical Journal"},{"key":"10.1016\/j.jsat.2018.07.002_bb0025","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1080\/02791072.2006.10399850","article-title":"Variations in drug users accounts of the connection between drug misuse and crime","volume":"38","author":"Bennett","year":"2006","journal-title":"Journal of Psychoactive Drugs"},{"key":"10.1016\/j.jsat.2018.07.002_bb9000","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1046\/j.1360-0443.2003.00264.x","article-title":"Male drugs-related deaths in the fortnight after release from prison: Scotland, 1996\u201399","volume":"98","author":"Bird","year":"2003","journal-title":"Addiction"},{"key":"10.1016\/j.jsat.2018.07.002_bb0030","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1940-0640-7-3","article-title":"Return to drug use and overdose after release from prison: A qualitative study of risk and protective factors","volume":"7","author":"Binswanger","year":"2012","journal-title":"Addiction Science & Clinical Practice"},{"key":"10.1016\/j.jsat.2018.07.002_bb0035","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1056\/NEJMsa064115","article-title":"Release from prison \u2013 A high risk of death for former inmates","volume":"356","author":"Binswanger","year":"2007","journal-title":"The New England Journal of Medicine"},{"year":"2017","series-title":"BNF74","author":"British National Formulary","key":"10.1016\/j.jsat.2018.07.002_bb0040"},{"key":"10.1016\/j.jsat.2018.07.002_bb0045","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.jsat.2011.06.006","article-title":"Criminal convictions among dependent heroin users during a 3-year period prior to opioid maintenance treatment: A longitudinal national cohort study","volume":"401","author":"Bukten","year":"2011","journal-title":"Journal of Substance Abuse Treatment"},{"year":"2017","series-title":"Drug misuse and dependence: UK guidelines on clinical management","author":"Clinical Guidelines on Drug Misuse and Dependence Update 2017 Independent Expert Working Group","key":"10.1016\/j.jsat.2018.07.002_bb0050"},{"key":"10.1016\/j.jsat.2018.07.002_bb0055","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/s002130100909","article-title":"Depot naltrexone: Long-lasting antagonism of the effects of heroin in humans","volume":"159","author":"Comer","year":"2002","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.jsat.2018.07.002_bb0060","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1001\/archpsyc.63.2.210","article-title":"Injectable, sustained-release naltrexone for the treatment of opioid dependence: A randomized, placebo-controlled trial","volume":"63","author":"Comer","year":"2006","journal-title":"Archives of General Psychiatry"},{"key":"10.1016\/j.jsat.2018.07.002_bb0065","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1111\/j.1521-0391.2010.00070.x","article-title":"A randomized trial of oral naltrexone for treating opioid dependent offenders","volume":"19","author":"Coviello","year":"2010","journal-title":"The American Journal on Addictions"},{"year":"2018","series-title":"European drug report 2018: Trends and developments","author":"European Monitoring Centre for Drugs and Drug Addiction","key":"10.1016\/j.jsat.2018.07.002_bb0070"},{"key":"10.1016\/j.jsat.2018.07.002_bb0075","doi-asserted-by":"crossref","first-page":"311","DOI":"10.5455\/bcp.20140310072258","article-title":"Predictors of outcome during a 6-month follow-up among heroin dependent patients receiving buprenorphine\/naloxone maintenance treatment","volume":"24","author":"Evren","year":"2014","journal-title":"Bulletin of Clinical Psychopharmaology"},{"key":"10.1016\/j.jsat.2018.07.002_bb0080","series-title":"Home office online report 40\/05","article-title":"Drug-related mortality among newly released offenders 1998 to 2000","author":"Farrell","year":"2005"},{"key":"10.1016\/j.jsat.2018.07.002_bb0085","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1111\/j.1360-0443.2007.02081.x","article-title":"Acute risk of drug related death among newly released prisoners in England and Wales","volume":"103","author":"Farrell","year":"2008","journal-title":"Addiction"},{"year":"1992","series-title":"GPower: a priori, post-hoc, and compromise power analyses for MS-DOS [computer program]","author":"Faul","key":"10.1016\/j.jsat.2018.07.002_bb0090"},{"key":"10.1016\/j.jsat.2018.07.002_bb0095","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.drugalcdep.2015.01.013","article-title":"Profiles of substance use disorders in patients of therapeutic communities: Link to social, medical, and psychiatric characteristics","volume":"149","author":"Fern\u00e1ndez-Calder\u00f3n","year":"2015","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.jsat.2018.07.002_bb0100","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.jsat.2017.04.010","article-title":"Initiation of extended release naltrexone (XR-NTX) for opioid use disorder prior to release from prison","volume":"85","author":"Friedman","year":"2018","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.jsat.2018.07.002_bb0110","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.jsat.2015.07.005","article-title":"A phase 4, pilot, open-label study of VIVITROL\u00ae (extended-release naltrexone XR-NTX) for prisoners","volume":"59","author":"Gordon","year":"2015","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.jsat.2018.07.002_bb0115","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.drugalcdep.2005.01.023","article-title":"Reductions in criminal convictions after addiction treatment: 5-year follow-up","volume":"79","author":"Gossop","year":"2005","journal-title":"Drug and Alcohol Dependence"},{"issue":"111","key":"10.1016\/j.jsat.2018.07.002_bb0120","article-title":"Risk factors for criminal recidivism \u2013 A prospective follow-up study in prisoners with substance abuse","volume":"12","author":"H\u00e5kansson","year":"2012","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.jsat.2018.07.002_bb0125","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1080\/14659890600708266","article-title":"Factors associated with relapse among clients in Australian substance disorder treatment facilities","volume":"11","author":"Hammerbacher","year":"2006","journal-title":"Journal of Substance Use"},{"key":"10.1016\/j.jsat.2018.07.002_bb0130","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.drugalcdep.2011.04.022","article-title":"Pathways to treatment retention for individuals legally coerced to substance use treatment: The interaction of hope and treatment motivation","volume":"118","author":"Hampton","year":"2011","journal-title":"Drug and Alcohol Dependence"},{"author":"House of Commons","key":"10.1016\/j.jsat.2018.07.002_bb0135"},{"key":"10.1016\/j.jsat.2018.07.002_bb0140","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1111\/j.1360-0443.2011.03443.x","article-title":"Mortality among a cohort of drug users after their release from prison: An evaluation of the effectiveness of a harm reduction program in Taiwan","volume":"106","author":"Huang","year":"2011","journal-title":"Addiction"},{"key":"10.1016\/j.jsat.2018.07.002_bb0145","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/j.jcps.2014.12.002","article-title":"Toward a more nuanced understanding of the statistical properties of a median split","volume":"25","author":"Iacobucci","year":"2015","journal-title":"Journal of Consumer Psychology"},{"key":"10.1016\/j.jsat.2018.07.002_bb0150","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1093\/ije\/dyl225","article-title":"Extreme cause-specific mortality in a cohort of adult prisoners \u2013 1988 to 2002: A data-linkage study","volume":"36","author":"Kariminia","year":"2007","journal-title":"International Journal of Epidemiology"},{"key":"10.1016\/j.jsat.2018.07.002_bb0155","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0376-8716(98)00107-0","article-title":"The onset of heroin use and criminal behaviour: Does order make a difference","volume":"53","author":"Kaye","year":"1998","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.jsat.2018.07.002_bb0160","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.addbeh.2009.11.005","article-title":"Psychometric validation of the Leeds Dependence Questionnaire (LDQ) in a young adult clinical sample","volume":"35","author":"Kelly","year":"2010","journal-title":"Addictive Behaviors"},{"key":"10.1016\/j.jsat.2018.07.002_bb0165","doi-asserted-by":"crossref","first-page":"1,506","DOI":"10.1016\/S0140-6736(11)60358-9","article-title":"Injectable extended-release naltrexone for opioid dependence: A double-blind, placebo-controlled, multicentre randomised trial","volume":"377","author":"Krupitsky","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.jsat.2018.07.002_bb0170","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1097\/YCO.0b013e3283386578","article-title":"Long-acting depot formulations of naltrexone for heroin dependence: A review","volume":"23","author":"Krupitsky","year":"2010","journal-title":"Current Opinion in Psychiatry"},{"key":"10.1016\/j.jsat.2018.07.002_bb0175","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/dar.12095","article-title":"A systematic review and meta-analysis of naltrexone implants for the treatment of opioid dependence","volume":"33","author":"Larney","year":"2014","journal-title":"Drug and Alcohol Review"},{"key":"10.1016\/j.jsat.2018.07.002_bb0180","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1111\/add.12894","article-title":"Opioid treatment at release from jail using extended-release naltrexone: A pilot proof of concept randomized effectiveness trial","volume":"110","author":"Lee","year":"2015","journal-title":"Addiction"},{"key":"10.1016\/j.jsat.2018.07.002_bb0185","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1007\/s40263-013-0111-9","article-title":"Scopolamine detoxification technique for heroin dependence: A randomized trial","volume":"27","author":"Liu","year":"2013","journal-title":"CNS Drugs"},{"key":"10.1016\/j.jsat.2018.07.002_bb0190","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1159\/000313336","article-title":"Naltrexone implants compared to methadone: Outcomes 6 months after prison release","volume":"16","author":"Lobmaier","year":"2010","journal-title":"European Addiction Research"},{"key":"10.1016\/j.jsat.2018.07.002_bb0195","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1111\/j.1755-5949.2010.00194.x","article-title":"Naltrexone depot formulations for opioid and alcohol dependence: A systematic review","volume":"17","author":"Lobmaier","year":"2011","journal-title":"CNS Neuroscience & Therapeutics"},{"key":"10.1016\/j.jsat.2018.07.002_bb0200","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.jsat.2015.11.004","article-title":"\u201cI kicked the hard way. I got incarcerated.\u201d withdrawal from methadone during incarceration and subsequent aversion to medication assisted treatments","volume":"62","author":"Maradiaga","year":"2016","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.jsat.2018.07.002_bb0205","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1001\/archpsyc.1973.01750360022003","article-title":"Naltrexone, an antagonist for the treatment of heroin dependence: Effects in man","volume":"28","author":"Martin","year":"1973","journal-title":"Archives of General Psychiatry"},{"key":"10.1016\/j.jsat.2018.07.002_bb0210","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1111\/j.1360-0443.2010.02990.x","article-title":"Meta-analysis of drug-related deaths soon after release from prison","volume":"105","author":"Merrall","year":"2010","journal-title":"Addiction"},{"key":"10.1016\/j.jsat.2018.07.002_bb0215","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1037\/0893-164X.10.2.81","article-title":"Assessing drinkers' motivation to change: The States of Change Readiness and Treatment Eagerness Scale (SOCRATES)","volume":"10","author":"Miller","year":"1996","journal-title":"Psychology of Addictive Behaviors"},{"key":"10.1016\/j.jsat.2018.07.002_bb0220","doi-asserted-by":"crossref","first-page":"141","DOI":"10.3109\/00952990.2010.538943","article-title":"A pilot assessment of relapse prevention for heroin addicts in a Chinese rehabilitation center","volume":"37","author":"Min","year":"2011","journal-title":"The American Journal of Drug and Alcohol Abuse"},{"issue":"4","key":"10.1016\/j.jsat.2018.07.002_bb0225","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD001333.pub3","article-title":"Oral naltrexone maintenance treatment for opioid dependence","author":"Minozzi","year":"2011","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1016\/j.jsat.2018.07.002_bb0230","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1080\/02791072.2009.10399907","article-title":"Incarceration and opioid withdrawal: The experiences of methadone patients and out-of-treatment heroin users","volume":"41","author":"Mitchell","year":"2009","journal-title":"Journal of Psychoactive Drugs"},{"key":"10.1016\/j.jsat.2018.07.002_bb0235","first-page":"77","article-title":"Attempted cessation of heroin use among men approaching mid-life","volume":"13","author":"Mullen","year":"2006","journal-title":"Drugs: Education, Prevention and Policy"},{"key":"10.1016\/j.jsat.2018.07.002_bb0240","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1111\/j.1360-0443.1992.tb02698.x","article-title":"Motivation to withdraw from heroin: A factor analytic study","volume":"87","author":"Murphy","year":"1992","journal-title":"British Journal of Addiction"},{"key":"10.1016\/j.jsat.2018.07.002_bb0245","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1037\/0893-164X.17.2.167","article-title":"Predicting post-discharge opiate abstinence from admission measures of motivation and confidence","volume":"17","author":"Murphy","year":"2003","journal-title":"Psychology of Addictive Behaviors"},{"year":"2007","series-title":"Naltrexone for the management of opioid dependence","author":"NICE","key":"10.1016\/j.jsat.2018.07.002_bb0250"},{"key":"10.1016\/j.jsat.2018.07.002_bb0255","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1111\/add.13668","article-title":"Randomized controlled pilot trial of naloxone-on-release to prevent post-prison opioid overdose deaths","volume":"112","author":"Parmar","year":"2016","journal-title":"Addiction"},{"author":"Prison Reform Trust","key":"10.1016\/j.jsat.2018.07.002_bb0260"},{"key":"10.1016\/j.jsat.2018.07.002_bb0265","series-title":"Treating addictive behaviors: Processes of change","first-page":"3","article-title":"Toward a comprehensive model of change","author":"Prochaska","year":"1986"},{"key":"10.1016\/j.jsat.2018.07.002_bb0270","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1111\/j.1360-0443.1994.tb03332.x","article-title":"Development of the Leeds Dependence Questionnaire","volume":"89","author":"Raistrick","year":"1994","journal-title":"Addiction"},{"key":"10.1016\/j.jsat.2018.07.002_bb0275","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.eurpsy.2010.10.001","article-title":"Differences in drug consumption, comorbidity, and health service use across six European urban regions (TREAT-project)","volume":"27","author":"Reissner","year":"2012","journal-title":"European Psychiatry"},{"key":"10.1016\/j.jsat.2018.07.002_bb0280","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/S0140-6736(14)62338-2","article-title":"Methadone continuation versus forced withdrawal on incarceration in a combined US prison and jail: A randomised, open-label trial","volume":"386","author":"Rich","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.jsat.2018.07.002_bb0285","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1007\/s002130051045","article-title":"Onset, magnitude and duration of opioid blockade produced by buprenorphine and naltrexone in humans","volume":"145","author":"Schuh","year":"1999","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.jsat.2018.07.002_bb0290","series-title":"Findings 187","article-title":"Drug-related mortality among newly released offenders","author":"Singleton","year":"2003"},{"key":"10.1016\/j.jsat.2018.07.002_bb0295","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1046\/j.1360-0443.1999.94572310.x","article-title":"A brief measure for the assessment of coping self-efficacy","volume":"94","author":"Sklar","year":"1999","journal-title":"Addiction"},{"key":"10.1016\/j.jsat.2018.07.002_bb0300","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1002\/cbm.339","article-title":"Drug misuse and acquisitive crime among clients recruited to the National Treatment Research Outcome Research Study (NTORS)","volume":"10","author":"Stewart","year":"2000","journal-title":"Criminal Behaviour and Mental Health"},{"key":"10.1016\/j.jsat.2018.07.002_bb0305","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/add.12904","article-title":"Death matters: Understanding heroin\/opiate overdose risk and testing potential to prevent deaths","volume":"110","author":"Strang","year":"2015","journal-title":"Addiction"},{"key":"10.1016\/j.jsat.2018.07.002_bb0315","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.drugalcdep.2013.05.030","article-title":"Naltrexone treatment for opioid dependence: Does its effectiveness depend on testing the blockade?","volume":"133","author":"Sullivan","year":"2013","journal-title":"Drug and Alcohol Dependence"},{"year":"2014","series-title":"Using multivariate statistics","author":"Tabachnick","key":"10.1016\/j.jsat.2018.07.002_bb0320"},{"key":"10.1016\/j.jsat.2018.07.002_bb0325","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/s11469-017-9782-7","article-title":"Relapse risk factors in heroin addicts treated with naltrexone and naltrexone-behavioural psychotherapy","volume":"16","author":"Tasi\u0107","year":"2018","journal-title":"International Journal of Mental Health and Addiction"},{"key":"10.1016\/j.jsat.2018.07.002_bb0330","doi-asserted-by":"crossref","first-page":"60","DOI":"10.3109\/14659890903010501","article-title":"Family ties and the frequency of heroin use","volume":"15","author":"Tseng","year":"2010","journal-title":"Journal of Substance Use"},{"key":"10.1016\/j.jsat.2018.07.002_bb0335","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.jsat.2014.02.008","article-title":"An evaluation of hepatic enzyme elevations among HIV-infected released prisoners enrolled in two randomised placebo controlled trials of extended release naltrexone","volume":"47","author":"Vagenas","year":"2014","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.jsat.2018.07.002_bb0340","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1016\/j.addbeh.2013.03.009","article-title":"Participation in opioid substitution treatment reduces the rate of criminal convictions: Evidence from a community study","volume":"38","author":"Vorma","year":"2013","journal-title":"Addictive Behaviors"},{"key":"10.1016\/j.jsat.2018.07.002_bb0345","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1111\/j.1521-0391.2013.12085.x","article-title":"Phase 1 study of injectable, depot, naltrexone for the relapse prevention treatment of opioid dependence","volume":"23","author":"Wang","year":"2014","journal-title":"The American Journal on Addictions"},{"key":"10.1016\/j.jsat.2018.07.002_bb0350","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1080\/02791072.2014.890765","article-title":"(2014). Understanding prolonged cessation from heroin use: Findings from a community-based sample","volume":"46","author":"Weiss","year":"2014","journal-title":"Journal of Psychoactive Drugs"},{"year":"2014","series-title":"Preventing overdose deaths in the criminal-justice system","author":"World Health Organisation","key":"10.1016\/j.jsat.2018.07.002_bb0355"},{"key":"10.1016\/j.jsat.2018.07.002_bb0360","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1080\/10826084.2016.1201117","article-title":"Acceptability of extended-release naltrexone by heroin dependent patients and addiction treatment providers in the Netherlands","volume":"51","author":"Zaaijer","year":"2016","journal-title":"Substance Use and Misuse"}],"container-title":["Journal of Substance Abuse Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0740547218300345?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0740547218300345?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T19:49:02Z","timestamp":1760039342000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0740547218300345"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":71,"alternative-id":["S0740547218300345"],"URL":"https:\/\/doi.org\/10.1016\/j.jsat.2018.07.002","relation":{},"ISSN":["0740-5472"],"issn-type":[{"type":"print","value":"0740-5472"}],"subject":[],"published":{"date-parts":[[2018,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"High drug related mortality rates following prison release: Assessing the acceptance likelihood of a naltrexone injection and related concerns","name":"articletitle","label":"Article Title"},{"value":"Journal of Substance Abuse Treatment","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jsat.2018.07.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}